A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
Tuberculosis (TB) is one of the world's leading causes of death due to infection and efforts to control TB would be substantially aided by the availability of an improved TB vaccine. There are currently nine new TB vaccines in clinical development, and the first efficacy trials are due to comme...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2009
|
| _version_ | 1797082751481937920 |
|---|---|
| author | Fletcher, H Hawkridge, T Mcshane, H |
| author_facet | Fletcher, H Hawkridge, T Mcshane, H |
| author_sort | Fletcher, H |
| collection | OXFORD |
| description | Tuberculosis (TB) is one of the world's leading causes of death due to infection and efforts to control TB would be substantially aided by the availability of an improved TB vaccine. There are currently nine new TB vaccines in clinical development, and the first efficacy trials are due to commence in 2009. There are many complex ethical issues which arise at all stages of TB vaccine development, from the need to conduct trials in developing countries to informed consent and the process of ethical review. While it is important that these issues are discussed, it may also be timely to consider the challenges which may arise if a vaccine in clinical development proves to be highly effective. We examine a number of scenarios where decisions on the deployment of a new TB vaccine may impact on the rights and liberty of the individual. © The Author(s) 2009. |
| first_indexed | 2024-03-07T01:32:16Z |
| format | Journal article |
| id | oxford-uuid:93fdbc8a-f8b0-4b91-b5d7-6380bbc0e516 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T01:32:16Z |
| publishDate | 2009 |
| record_format | dspace |
| spelling | oxford-uuid:93fdbc8a-f8b0-4b91-b5d7-6380bbc0e5162022-03-26T23:36:09ZA New Vaccine for Tuberculosis: The Challenges of Development and DeploymentJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:93fdbc8a-f8b0-4b91-b5d7-6380bbc0e516EnglishSymplectic Elements at Oxford2009Fletcher, HHawkridge, TMcshane, HTuberculosis (TB) is one of the world's leading causes of death due to infection and efforts to control TB would be substantially aided by the availability of an improved TB vaccine. There are currently nine new TB vaccines in clinical development, and the first efficacy trials are due to commence in 2009. There are many complex ethical issues which arise at all stages of TB vaccine development, from the need to conduct trials in developing countries to informed consent and the process of ethical review. While it is important that these issues are discussed, it may also be timely to consider the challenges which may arise if a vaccine in clinical development proves to be highly effective. We examine a number of scenarios where decisions on the deployment of a new TB vaccine may impact on the rights and liberty of the individual. © The Author(s) 2009. |
| spellingShingle | Fletcher, H Hawkridge, T Mcshane, H A New Vaccine for Tuberculosis: The Challenges of Development and Deployment |
| title | A New Vaccine for Tuberculosis: The Challenges of Development and Deployment |
| title_full | A New Vaccine for Tuberculosis: The Challenges of Development and Deployment |
| title_fullStr | A New Vaccine for Tuberculosis: The Challenges of Development and Deployment |
| title_full_unstemmed | A New Vaccine for Tuberculosis: The Challenges of Development and Deployment |
| title_short | A New Vaccine for Tuberculosis: The Challenges of Development and Deployment |
| title_sort | new vaccine for tuberculosis the challenges of development and deployment |
| work_keys_str_mv | AT fletcherh anewvaccinefortuberculosisthechallengesofdevelopmentanddeployment AT hawkridget anewvaccinefortuberculosisthechallengesofdevelopmentanddeployment AT mcshaneh anewvaccinefortuberculosisthechallengesofdevelopmentanddeployment AT fletcherh newvaccinefortuberculosisthechallengesofdevelopmentanddeployment AT hawkridget newvaccinefortuberculosisthechallengesofdevelopmentanddeployment AT mcshaneh newvaccinefortuberculosisthechallengesofdevelopmentanddeployment |